Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 5Phase NA 2Phase 1/2 1

Status

Completed 4Terminated 1

Sponsor Class

OTHER 3NIH 1NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Sarcoma 5Other hematologic neoplasm 1Lymphoid 1CNS 1

Conditions

Colorectal Neoplasms 56Rectal Neoplasms 30Colonic Neoplasms 29Pancreatic Neoplasms 28Neoplasms 20Neoplasm Metastasis 18Stomach Neoplasms 17Carcinoma, Non-Small-Cell Lung 14Unspecified Adult Solid Tumor, Protocol Specific 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Myeloid, Acute 8Esophageal Neoplasms 8Ovarian Neoplasms 7Lymphoma, Non-Hodgkin 7Lymphoma 7Adenocarcinoma 7Myelodysplastic Syndromes 6Lung Neoplasms 6Gallbladder Neoplasms 6Breast Neoplasms 6Sarcoma 5Osteosarcoma 5Liver Neoplasms 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hodgkin Disease 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Bile Duct Neoplasms 5Triple Negative Breast Neoplasms 4Solid Tumor 4

Interventions

Cyclophosphamide 14Gemcitabine 6Filgrastim 6fludarabine 5Methotrexate 5Leucovorin 5Granulocyte Colony-Stimulating Factor 5Zoledronic Acid 4Temozolomide 4Mesna 4Irinotecan 4Ifosfamide 4Etoposide 4Cisplatin 4Carboplatin 4pembrolizumab 3fludarabine phosphate 3Doxorubicin 3Biopsy 3tanespimycin 2poly ICLC 2pegfilgrastim 2lorukafusp alfa 2liposomal doxorubicin 2dinutuximab 2cabozantinib 2belinostat 2Topotecan 2Thalidomide 2Specimen Handling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Osteosarcoma × Leucovorin × Clear all
NCT00634504 2022-06-06

LVPK

BTG International Inc.

Phase 1 Completed
20 enrolled 9 charts
LymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Osteosarcoma, Renal Insufficiency

NCT00742924 2014-07-04

Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma

Children's Oncology Group

Phase 1 Completed
24 enrolled 9 charts
Sarcoma

Sarcoma, Osteosarcoma

NCT01258634 2013-12-10

A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response

University of Chicago

Phase 1 Terminated
2 enrolled
Sarcoma

Osteosarcoma

NCT00513981 2013-06-26

High-Dose Methotrexate in Treating Young Patients With Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
36 enrolled
CNSSarcoma

Familial ependymoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms

NCT00119301 2013-01-17

Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent Osteosarcoma

Memorial Sloan Kettering Cancer Center

Phase 1 Completed
18 enrolled
Sarcoma

Sarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡